Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,749 | -4,641 | -2,311 | -13,447 | -11,572 |
| Depreciation Amortization | 546 | 370 | 187 | 721 | 536 |
| Accounts payable and accrued liabilities | -261 | -628 | -246 | 111 | 157 |
| Other Working Capital | -115 | -482 | -205 | 120 | 237 |
| Other Operating Activity | 593 | 830 | 340 | 5,830 | 5,685 |
| Operating Cash Flow | $-5,986 | $-4,551 | $-2,236 | $-6,666 | $-4,957 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -154 | -44 | -35 | -9 | -4 |
| Investing Cash Flow | $-154 | $-44 | $-35 | $-9 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,255 | 1,100 |
| Common Stock Issued | 16,564 | 10,442 | 10,442 | 16,677 | 7,458 |
| Other Financing Activity | -1,233 | -1,163 | -88 | -105 | -46 |
| Financing Cash Flow | $15,331 | $9,279 | $10,354 | $17,828 | $8,512 |
| Beginning Cash Position | 13,709 | 13,709 | 13,709 | 2,555 | 2,555 |
| End Cash Position | 22,900 | 18,393 | 21,792 | 13,709 | 6,106 |
| Net Cash Flow | $9,191 | $4,685 | $8,083 | $11,153 | $3,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,986 | -4,551 | -2,236 | -6,666 | -4,957 |
| Capital Expenditure | -154 | -44 | -35 | -9 | -4 |
| Free Cash Flow | -6,140 | -4,595 | -2,271 | -6,674 | -4,961 |